NMPA Approval

Compound Ipratropium Bromide Solution for Inhalation

Approval Number

国药准字H20244765

Company苏州弘森药业股份有限公司

Registration Date

August 27, 2024

Drug Information

Generic Name

吸入用复方异丙托溴铵溶液

Dosage Form

吸入制剂

Strength

2.5ml：异丙托溴铵0.5mg（按C₂₀H₃₀BrNO₃计）与沙丁胺醇2.5mg（按C₁₃H₂₁NO₃计）

Drug Type

化学药品

Registration Date

August 27, 2024

Company Information

Applicant Company

Company Name苏州弘森药业股份有限公司

Company Address

太仓港港口开发区石化区协鑫西路12号

Manufacturing Company

Company Name苏州弘森药业股份有限公司

Company Address

江苏太仓港港口开发区石化区协鑫西路12号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

吸入用复方异丙托溴铵溶液 - NMPA 批准文号 | MedPath